Varian’s Post

🎙️NEW #AHA23 #LBCT Discussion 💫Dr Mandeep Mehra, MD, MSc, FRCP (London) joins Dr Harriette Van Spall to discuss the ARIES HM3 clinical trial. 📽️Watch in full here👉 https://ow.ly/n1ih50Q6GQ3 📊Omission of aspirin from an antithrombotic regimen including a VKA in advanced heart failure patients with LVAD was associated with a reduction in bleeding events and a 47% decrease in the number of hospitalisation days without an increased risk of thromboembolic events. #Cardiology #ClinicalTrial #CardioEd

Join us for February's webinar on Radiotherapy with speaker Ryan Yeo, Radiation Therapist. Topics: - What is radiotherapy? - What do patients experience? - What do nurses need to know about radiotherapy and side effects in their patients? Register here 👉 https://loom.ly/GBMvYtQ #HealthcareWebinar #ProfessionalDevelopment #NursingWebinar #AlbertaHealthcare

How do the 2022 ESC/IC-OS guidelines on cardio-oncology impact your practice? Join us today to learn more - https://ow.ly/HtMz50PL0VW Obtain a comprehensive understanding, including the latest advancements and recommendations. ☠️ Stratifying cardiovascular toxicity risk 🔎 Identify high-risk patients 🩺 Early detection and management #CardioOncology #CVD #ESCGuidelines #ICOS #Cardiology

DOES SIZE REALLY MATTER? Continued from previous post …(results of treatment) Patient chose the option of thermal ablation by pinhole approach ( RadioFrequency Ablation) after detailed discussion of all the options A-D . Achieved 80% reduction in volume ( from 240 ml to 48 ml) 6 months post 2 sessions of RFA StarMed Healthcare Patient is very happy with the results. Aiden Lee Jung Hwan Baek RFAMD #rfa #thyroid #thyroidawareness #thyroidhealth #interventionalradiology #interventionaloncology #minimallyinvasive

https://lnkd.in/gHxe87PG The optimal antithrombotic strategy to prevent CABG occlusion while minimizing bleeding risks remains uncertain. We conducted a review of randomized clinical trials and meta-analyses of antithrombotic therapy for patients with CABG, with the aim to inform clinical decision-making on the best choices for individual patients. #CABG #Cardiology #GraftFailure #Antithrombotics #Coronary

On demand | A New Momentum for Renal Denervation: 2023 ESH Guidelines. Catch up here! ➡️ https://ow.ly/6ljy50QrF0i Dr Joost Daemen and Prof Dagmara Hering deliver a compelling discussion that provides an update on: ✅2023 ESH guidelines about Renal Denervation ✅The class of recommendation and level of evidence ✅Ultrasound RDN clinical evidence ✅Recommended patient pathways and hear case discussions #RDN #Cardiology #MedEd

🤔 Should patients have to wait anxiously for an appointment that only serves to give good news? We know that many of our specialists use our ‘Advice & Guidance’ feature to quickly respond to GPs and patients about non-urgent referrals. One important use case is when a GP makes an incidental finding on imaging or pathology, and a referral is sent to a specialist to investigate this further. Typically, time would first be spent making the appointment and freeing up schedules to attend it. Leading up to the appointment, the patient and their carers will be understandably anxious and unnecessarily so; They would simply be told the good news that this is just an incidental finding. Consultmed’s Advice & Guidance feature allows for asynchronous, secure communication back to the referrer. In this use case, immediate advice that the finding is normal would be communicated immediately and securely to the GP, saving valuable time, as well as unnecessary anxiety. 🗞️🗞️Check the link below to read Dr Pam Rachootin’s article! https://lnkd.in/gVySxbuc

In patients with STEMI transferred for primary PCI, pretreatment with P2Y12 inhibitors significantly reduced the risk of 30-day major adverse cardiac events (MACE) without increasing bleeding risk, particularly when administered more than 80 minutes before PCI. This suggests that early administration of P2Y12 inhibitors can provide a superior net clinical benefit compared to in-cath lab administration. More info on the latest #ESCTVToday episode. https://bit.ly/3zGzZQY Sign up for reminders so you Never Miss a Beat https://bit.ly/3IQ1B7G #Cardiovascular #Cardiology

Better longterm (5 year) patient outcomes reveal the true clinical power of hsTn. It’s not only about infarct, this High-STEACS secondary analysis shows that identifying non-ischemic myocardial injury can help patients with pathology which needs something other than an urgent cardiac cath. The more early myocardial injury that can be identified, the more value-based outcomes patients can receive from hsTn.

Live TODAY | Latest Clinical Trial Updates for ATTR-CM and AL-CM!📊 Tune in at 14:00 GMT / 09:00 EST 🔗 https://ow.ly/stXO50QyJrg 🥼Dr Michelle Kittleson 🥼Dr Heather Landau 🥼Prof Dan Lenihan 🥼Prof Joe Carver Learn about ongoing clinical, emerging therapeutic modalities and the evolving landscape of patient management. #CardioOnc #Cardiology